CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · Real-Time Price · USD
0.275
+0.026 (10.32%)
Nov 21, 2024, 11:34 AM EST - Market open
CERO Employees
As of December 31, 2023, CERo Therapeutics Holdings had 9 total employees, including 8 full-time and 1 part-time employees.
Employees
9
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$738,631
Market Cap
41.26M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| RAPT Therapeutics | 131 |
| Beyond Air | 107 |
| Rallybio | 43 |
| Lumos Pharma | 33 |
| VYNE Therapeutics | 10 |
| Incannex Healthcare | 9 |
| Lexaria Bioscience | 5 |
| Anebulo Pharmaceuticals | 3 |
CERO News
- 6 days ago - CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia - GlobeNewsWire
- 10 days ago - CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity - GlobeNewsWire
- 4 weeks ago - CERo Therapeutics, Inc. Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer - GlobeNewsWire
- 2 months ago - Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump - Benzinga
- 2 months ago - CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236 - GlobeNewsWire
- 4 months ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July - Benzinga
- 5 months ago - CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236 - GlobeNewsWire